论文部分内容阅读
目的:研究上海市肺癌患者的疾病经济负担。方法:随机抽取上海市某家以诊治心肺疾病为主的三甲专科医院的上海市户籍肺癌患者1 280例,收集患者社会人口学特征、疾病特征、卫生服务利用及各项费用等信息。采用二步模型法和人力资本法对样本肺癌患者的疾病经济负担进行估算。结果:肺癌患者年人均疾病经济负担为62 401.64元,其中直接医疗费用为57 295.59元,所占比例为91.82%,远远超过其他构成。直接非医疗费用为757.72元,间接经济负担为4 348.33元。结论:上海市肺癌患者的疾病经济负担沉重,应规范医疗机构合理用药,提高肺癌相关药品费用的报销比例,减轻患者负担。
Objective: To study the economic burden of disease in patients with lung cancer in Shanghai. Methods: A total of 1280 cases of lung cancer in Shanghai were collected from a Shanghai Special Administrative Region hospital specializing in the diagnosis and treatment of cardiopulmonary diseases. The demographic characteristics, disease characteristics, utilization of health services and various costs were collected. The two-step model and the human capital approach were used to estimate the economic burden of disease in patients with lung cancer. Results: The average annual economic burden of patients with lung cancer was 62,401.64 yuan, of which the direct medical costs were 57,295.59 yuan, accounting for 91.82%, far more than other components. The direct non-medical expenses were 757.72 yuan and the indirect economic burden was 4 348.33 yuan. Conclusion: The economic burden of lung cancer patients in Shanghai is heavy. It is necessary to regulate the rational use of drugs in medical institutions, increase the reimbursement proportion of the cost of lung cancer-related drugs and reduce the burden on patients.